Sexually Transmitted Disease (STD) Testing Market is analyzed across North America, Asia-Pacific, Europe & LAMEA
Rising number of patients with chronic diseases is further fueling the growth of the global STD testing market.
PORTLAND, OREGON, USA, Sept. 13, 2022 /EINPresswire.com/ — Sexually transmitted disease market growth is being greatly driven by high incidence rates and rising prevalence rates of sexually transmitted diseases such as chlamydia , syphilis and gonorrhea. In addition, the implementation of national screening programs to improve and increase the diagnosis of sexually transmitted diseases in many key geographic areas, such as the 𝐔𝐧𝐢𝐭𝐞𝐝 𝐒𝐭𝐚𝐭𝐞𝐬, 𝐔𝐧𝐢𝐭𝐞𝐝 𝐊𝐢𝐧𝐠𝐝𝐨𝐦 𝐚𝐧𝐝 𝐂𝐚𝐧𝐚𝐝𝐚, and the support in reimbursement of STD testing, further support the growth of the sexually transmitted disease (STD) testing market.
♦ 𝐅𝐨𝐫 𝐑𝐢𝐠𝐡𝐭 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞 𝐚𝐧𝐝 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐆𝐞𝐭 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-sample/385
However, there is a social stigma associated with patients visiting sexually transmitted disease clinics that prevent patients from being diagnosed with sexually transmitted diseases. Additionally, a large percentage of STD patients are found in out-of-reach geographic areas, which greatly limits the diagnosis of STDs. These factors are expected to restrain the growth of the STD testing market.
“Sexually Transmitted Disease (STD) Testing Market by Disease Type (Chlamydia, Gonorrhea, Herpes Simplex Virus, Syphilis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV) and Other Diseases) and Location of Testing (Laboratory Testing and Point-of-Care (POC) Testing: Global Opportunities Analysis and Industry Forecast, 2021-2030″.
Drivers, constraints and opportunities –
High prevalence and incidence of STDs, support for reimbursement of STD testing, and implementation of national screening programs have fueled the growth of the global STD (STD) testing market. However, the large proportion of STD patients in remote areas, the stringent regulatory compliance requirements for STD market participants, the large number of STD patients in remote areas, and the social stigma associated with patient visits in sexually transmitted disease clinics are hampering the growth of the market. . On the contrary, the reduction in the number of visits to government clinics, national screening programs and advances in POC testing and technology are expected to open up new opportunities in the future.
𝐀𝐬𝐢𝐚-𝐏𝐚𝐜𝐢𝐟𝐢𝐜, 𝐟𝐨𝐥𝐥𝐨𝐰𝐞𝐝 𝐛𝐲 𝐋𝐀𝐌𝐄𝐀 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐀𝐦𝐞𝐫𝐢𝐜𝐚, 𝐡𝐞𝐥𝐝 𝐥𝐢𝐨𝐧’𝐬 𝐬𝐡𝐚𝐫𝐞
By region, Asia-Pacific, followed by LAMEA and North America, led the market in 2020, contributing more than half of the market. Moreover, the region is expected to register the highest CAGR of 5.3% during the forecast period, owing to the increasing cases of sexually transmitted diseases in emerging countries and increased patient awareness through education campaigns.
By region, North America is expected to witness the market growth at the highest rate, registering a CAGR of 6.4% during the forecast period.
♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐒𝐓𝐃 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresesearch.com/purchase-enquiry/385
This report provides a comprehensive competitive analysis of major market key players such as –
Becton Dickinson Company,
Bio-Rad Laboratories, Inc.,
Molecular Diasorin LLC,
Orasure Technologies, Inc.,
Roche Holding AG and
Thermo Fisher Scientific Inc.
Gonorrhea Segment Will Manifest Highest Through 2030
By disease type, the gonorrhea segment is expected to show the highest CAGR of 7.3% during the forecast period. However, the Chlamydia testing segment dominated the market in 2020, accounting for more than a quarter of the market, due to a lack of knowledge about sexually transmitted diseases among the population and a lack of protective barriers. The laboratory testing segment dominated the market.
The laboratory testing segment dominated the market
By testing location, the laboratory testing segment constituted the lion’s share in 2020, contributing more than four-fifths of the market, as the majority of diagnostic testing cases take place in laboratories. However, the point-of-care testing segment is expected to register the highest CAGR of 6.3% between 2021 and 2030, owing to untapped markets in developing countries.
Main results of the study –
By intubation, the orotracheal intubation segment held the largest share of the sexually transmitted disease (STD) testing market in 2020 and is expected to remain dominant during the forecast period.
By application, the anesthesia segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
By end-user, the hospital segment held the largest STD testing market share in 2020 and is expected to remain dominant during the forecast period.
Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unrivaled quality of “market research reports” and “Business Intelligence solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.
Pawan Kumar, CEO of Allied Market Research, leads the organization in delivering high quality data and insights. We are in professional corporate relations with vario research data tables and confirm the utmost accuracy in our market forecasts. Each of our companies and this helps us to extract market data which helps us to generate accurate data presented in the reports that we publish are extracted through primary interviews with senior officials of the main companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.
Allied Analytics LLP
write to us here
Visit us on social media: